Tiny implant could free glaucoma patients from daily eye drops
NCT ID NCT04060758
Summary
This early-stage study tested a small, dissolving implant placed inside the eye to slowly release glaucoma medication over time. It involved 37 adults with mild-to-moderate glaucoma to find the safest and most effective dose. The goal was to see if this one-time implant could control eye pressure as well as or better than daily eye drops.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bendigo Eye Clinic
Bendigo, Victoria, 3550, Australia
-
Capital Eye Specialists
Te Aro, 6011, New Zealand
-
Centre for Eye Research Australia
East Melbourne, Victoria, 3002, Australia
-
Essendon Eye Clinic
Essendon, Victoria, 3040, Australia
-
Eye Surgery Associates
Vermont South, Victoria, 3133, Australia
-
Eyes First
Springvale, Victoria, 3171, Australia
-
Goodwood Eye Centre
Millswood, South Australia, 5034, Australia
-
Melbourne Eye Specialists
Fitzroy, Victoria, 3065, Australia
-
PersonalEYES
Castle Hill, New South Wales, 2150, Australia
Conditions
Explore the condition pages connected to this study.